|
Penas-Martinez J, Barrachina MN, Cuenca-Zamora EJ, Luengo-Gil G, Bravo SB, Caparros-Perez E, Teruel-Montoya R, Eliseo-Blanco J, Vicente V, Garcia A, Martinez-Martinez I, Ferrer-Marin F. Qualitative and Quantitative Comparison of Plasma Exosomes from Neonates and Adults. Int J Mol Sci. 2021 Feb 15;22(4):1926. doi: 10.3390/ijms22041926. PubMed PMID: 33672065; PubMed Central PMCID: PMC7919666.
AÑO: 2021; IF: 6.208
|
33672065
|
Marce S, Xicoy B, Garcia O, Cabezon M, Estrada N, Velez P, Boque C, Sagues M, Angona A, Teruel-Montoya R, Ferrer-Marin F, Amat P, Hernandez-Boluda JC, Ibarra MM, Anguita E, Cortes M, Fernandez-Ruiz A, Fontanals S, Zamora L, On Behalf Of The Grupo Espanol de Leucemia Mieloide Cronica Gelmc. Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib. J Clin Med. 2021 Jul 16;10(14):3146. doi: 10.3390/jcm10143146. PubMed PMID: 34300312; PubMed Central PMCID: PMC8307111.
AÑO: 2021; IF: 4.964
|
|
Santaliestra M, Ferrer-Marin F, Alvarez-Larran A; MPN Spanish Group (GEMFIN). Review of the risk of thrombosis or bleeding upon abrupt anagrelide discontinuation in patients with essential thrombocythemia. Ann Hematol. 2022 Nov;101(11):2563-2564. doi: 10.1007/s00277-022-04956-y. Epub 2022 Aug 17. No abstract available. PubMed PMID: 35978180.
AÑO: 2022; IF: 3.5
|
|
Hernandez-Boluda JC, Pastor-Galan I, Arellano-Rodrigo E, Raya JM, Perez-Encinas M, Ayala R, Ferrer-Marin F, Velez P, Mora E, Fox ML, Hernandez-Rivas JM, Xicoy B, Mata-Vazquez MI, Garcia-Fortes M, Perez-Lopez R, Angona A, Cuevas B, Senin A, Ramirez MJ, Ramirez-Payer A, Gomez-Casares MT, Martinez-Valverde C, Magro E, Steegmann JL, Duran MA, Garcia-Hernandez C, Gasior M, de Villambrosia SG, Alvarez-Larran A, Pereira A; Spanish MPN Group (GEMFIN). Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis. Br J Haematol. 2022 Nov;199(4):529-538. doi: 10.1111/bjh.18440. Epub 2022 Sep 12. PubMed PMID: 36089912.
AÑO: 2022; IF: 6.5
|
|
Triguero A, Pedraza A, Perez-Encinas M, Mata-Vazquez MI, Velez P, Fox L, Gomez-Calafat M, Garcia-Delgado R, Gasior M, Ferrer-Marin F, Garcia-Gutierrez V, Angona A, Gomez-Casares MT, Cuevas B, Martinez C, Perez R, Raya JM, Guerrero L, Murillo I, Bellosillo B, Hernandez-Boluda JC, Sanz C, Alvarez-Larran A; On behalf of the MPN Spanish Group (GEMFIN). Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera. Ann Hematol. 2022 Oct;101(10):2231-2239. doi: 10.1007/s00277-022-04963-z. Epub 2022 Aug 30. Erratum In: Ann Hematol. 2022 Dec;101(12):2819-2820. PubMed PMID: 36042023; PubMed Central PMCID: PMC9584989.
AÑO: 2022; IF: 3.5
|